Secretin (human synthetic) - ChiRhoClin

DRUG2 trials

Sponsors

Johns Hopkins University, Mayo Clinic

Conditions

Chronic PancreatitisExocrine Pancreatic InsufficiencyPancreatic NeoplasmPeutz-Jeghers Syndrome

Phase 4

A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects

RecruitingNCT07285863

Mayo ClinicChronic Pancreatitis, Exocrine Pancreatic Insufficiency

Start: 2026-03-11End: 2028-03-01Target: 24Updated: 2026-07-07

Unknown Phase

Cancer of the Pancreas Screening Study (CAPS 3)

CompletedNCT00438906

Johns Hopkins UniversityPancreatic Neoplasm, Peutz-Jeghers Syndrome

Start: 2006-12-31End: 2009-12-31Updated: 2021-06-18

Related Papers

KRAS and guanine nucleotide-binding protein mutations in pancreatic juice collected from the duodenum of patients at high risk for neoplasia undergoing endoscopic ultrasound.

2014-12-0458 citations

Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia.

2012-11-28126 citations